Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 1.21% vs -10.04% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -15.67% vs -0.21% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "225.70",
          "val2": "223.00",
          "chgp": "1.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.10",
          "val2": "57.90",
          "chgp": "-30.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "3.20",
          "chgp": "6.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "2.90",
          "chgp": "-137.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "39.30",
          "val2": "46.60",
          "chgp": "-15.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "177.90%",
          "val2": "199.70%",
          "chgp": "-2.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.91% vs 19.96% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -26.79% vs 25.74% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "877.80",
          "val2": "836.70",
          "chgp": "4.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "214.20",
          "val2": "203.20",
          "chgp": "5.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.20",
          "val2": "4.70",
          "chgp": "180.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-42.30",
          "val2": "7.50",
          "chgp": "-664.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "120.50",
          "val2": "164.60",
          "chgp": "-26.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "185.70%",
          "val2": "196.10%",
          "chgp": "-1.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

225.70

223.00

1.21%

Operating Profit (PBDIT) excl Other Income

40.10

57.90

-30.74%

Interest

3.40

3.20

6.25%

Exceptional Items

-1.10

2.90

-137.93%

Consolidate Net Profit

39.30

46.60

-15.67%

Operating Profit Margin (Excl OI)

177.90%

199.70%

-2.18%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 1.21% vs -10.04% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -15.67% vs -0.21% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

877.80

836.70

4.91%

Operating Profit (PBDIT) excl Other Income

214.20

203.20

5.41%

Interest

13.20

4.70

180.85%

Exceptional Items

-42.30

7.50

-664.00%

Consolidate Net Profit

120.50

164.60

-26.79%

Operating Profit Margin (Excl OI)

185.70%

196.10%

-1.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.91% vs 19.96% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -26.79% vs 25.74% in Dec 2023

All Annual Results